EUVIMEDEUVIMED entdecken
Crossref

In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy

P. Suryadevara

International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e12

DOI: 10.1016/j.ijrobp.2026.02.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von P. Suryadevara.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Suryadevara, P. (2026). In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy. International Journal of Radiation Oncology*Biology*Physics, 125(1), e12. https://doi.org/10.1016/j.ijrobp.2026.02.026

Vancouver

Suryadevara P. In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e12. doi:10.1016/j.ijrobp.2026.02.026

BibTeX
@article{Suryadevara2026,
  author = {Suryadevara, P.},
  title = {In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {125},
  number = {1},
  pages = {e12},
  doi = {10.1016/j.ijrobp.2026.02.026}
}
Kostenlos starten →